Taking the epilepsy drug topiramate (Topamax) during pregnancy raises the danger of oral cleft birth defects such as cleft lip and cleft palate, according to a new warning issued by the FDA.
New drug registry data show that the threat of birth defect is up to 16 occasions greater amongst ladies who took topiramate or its generic equivalents during pregnancy.
Topiramate is approved by the FDA for treating seizures related with epilepsy and to prevent migraines. But it is also at times utilised on an off-label basis to treat other conditions, such as obesity, bipolar disorder, and alcoholism.
“Health care experts must meticulously take into account the benefits and risks of topiramate when prescribing it to females of childbearing age,” Russell Katz, MD, director of the Division of Neurology Merchandise in the FDA’s Center for Drug Evaluation and Study, says in a statement. “Option medicines that have a lower danger of birth defects must be deemed.”
Citing information from the North American Antiepileptic Drug (AED) Pregnancy Registry, the FDA says 1.4% of infants exposed to topiramate in the course of pregnancy created cleft lip or cleft palate, compared with .38-.55% of infants exposed to other epilepsy drugs. The threat of these oral cleft birth defects was considerably lower amongst infants of mothers who did not take epilepsy drugs throughout pregnancy (.07%). These alarming numbers have sparked some people’s interest in pursuing a Topamax birth defect lawsuit.
Related results have been reported in European drug registries.
Upgraded Pregnancy Warning
In response to this new info, the FDA says topiramate will have a stronger warning on its label. The warning in the pregnancy category has been changed from category C to a category D risk, which means there is positive evidence of fetal risk based on human data.
Cleft lip and cleft palate are birth defects that occur when parts of the lip or palate do not fuse together during the first trimester of pregnancy. The defects range from a tiny notch in the lip to a groove that runs into the roof of the mouth and nose that can lead to problems with eating and talking and to ear infections.
Researchers say with treatment, usually corrective surgery, most young children with cleft lip or cleft palate do nicely.
FDA officials warn that pregnant females and women of childbearing age should talk about other therapy options with their well being care specialist before taking topiramate. Women taking topiramate really should tell their wellness care skilled instantly if they are pregnant or organizing to turn into pregnant. Women who took Topamax during pregnancy and bore childrent with a Topamax birth defect should consider a topamax lawsuit.
People taking topiramate must not stop taking it unless told to do so by their medical doctor.